AI-assisted breathing test to check swollen chest lymph nodes
Part of Cancer, Lungs & breathing clinical trials.
This trial uses an AI-supported breathing procedure to help doctors examine enlarged lymph nodes in the chest when the cause is still unknown. It may help improve how accurately and efficiently doctors assess these lymph nodes so you can get answers sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You are being referred to a chest (thoracic) department because your mediastinal or hilar lymph nodes are enlarged and not diagnosed yet.
- Your healthcare team believes this specific chest lymph node problem fits this study.
- You are not pregnant.
- Your study doctor feels you are medically suitable to take part. (If they think it’s not right for you, you can’t enroll.)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using AI to help radiologists read lung CT scans can find cancer earlier and lower healthcare costs. You may qualify if you are at risk for lung cancer and have not been screened recently.
This trial tests an artificial intelligence platform that helps doctors predict if lymph nodes in the chest contain cancer during a routine ultrasound procedure. It aims to make staging more accurate for people with suspected or confirmed non-small cell lung cancer.
This trial uses artificial intelligence to improve low-dose CT scans for early lung cancer detection. If you are at higher risk due to smoking or family history, or just want a routine check, you may be able to join.
This study tests an artificial intelligence (AI) system that uses your health information and medical images to better judge cancer risk and support diagnosis and treatment decisions. It may help doctors make more consistent assessments by combining clinical records, imaging, and other lab-style data.
This trial tests whether using artificial intelligence (computer pattern-recognition) with lung screening images can help identify people who may have lung cancer earlier. It’s meant for people at higher risk because of their smoking history, who can follow the screening steps.
This study tests how well an AI tool can predict lung cancer risk, based on your health information. It looks at how patients feel about this approach to screening, with the goal of making screening more personal and effective.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.